Literature DB >> 22288596

Bronchoalveolar lavage cell pattern from healthy human lung.

M Heron1, J C Grutters, K M ten Dam-Molenkamp, D Hijdra, A van Heugten-Roeling, A M E Claessen, H J T Ruven, J M M van den Bosch, H van Velzen-Blad.   

Abstract

Bronchoalveolar lavage (BAL) is widely accepted as a key diagnostic procedure in interstitial lung diseases (ILD). We performed a study to obtain reference intervals of differential cell patterns in BAL fluid with special attention to the origin of lavage fluid, e.g. bronchial/alveolar, to atopy and smoking status and to age of the healthy people. We performed bronchoalveolar lavage in 55 healthy subjects with known atopy status (age: 18-64 years, non-smokers/smokers: 34/21) and determined differential cell counts and lymphocyte subsets in BAL fluid and blood. Moreover, in a subgroup of non-smoking healthy individuals we measured the expression of the regulatory T cell marker forkhead box protein 3 (FoxP3) on blood and BAL fluid lymphocytes in addition to a comprehensive set of activation markers. Differential cell counts from the alveolar lavage fraction differed significantly from calculated pooled fractions (n = 11). In contrast, marginal differences were found between atopic and non-atopic subjects. Interestingly, the BAL fluid CD4(+) /CD8(+) ratio correlated strongly with age (r(2) = 0·50, P < 0·0001). We consider the bronchial and alveolar fraction to be lavage fluid from fundamentally different compartments and recommend analysis of the alveolar fraction in diagnostic work-up of ILD. In addition, our data suggest that age corrected BAL fluid CD4(+) /CD8(+) ratios should be used in the clinical evaluation of patients with interstitial lung diseases.
© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22288596      PMCID: PMC3374285          DOI: 10.1111/j.1365-2249.2011.04529.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

1.  Variation of bronchoalveolar lymphocyte phenotypes with age in the physiologically normal human lung.

Authors:  K C Meyer; P Soergel
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.

Authors:  J Wahlström; M Berlin; C M Sköld; H Wigzell; A Eklund; J Grunewald
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

3.  The diagnostic value of bronchoalveolar lavage in immunocompetent children with chronic diffuse pulmonary infiltrates.

Authors:  L L Fan; M C Lung; J S Wagener
Journal:  Pediatr Pulmonol       Date:  1997-01

4.  Comparison of cell profiles in separately evaluated fractions of bronchoalveolar lavage (BAL) fluid in children.

Authors:  P Pohunek; H Pokorná; I Stríz
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

5.  Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin.

Authors:  K L Cepek; S K Shaw; C M Parker; G J Russell; J S Morrow; D L Rimm; M B Brenner
Journal:  Nature       Date:  1994-11-10       Impact factor: 49.962

6.  Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis.

Authors:  Valerie Guyot-Revol; John A Innes; Sarah Hackforth; Tim Hinks; Ajit Lalvani
Journal:  Am J Respir Crit Care Med       Date:  2005-12-09       Impact factor: 21.405

Review 7.  The role of bronchoalveolar lavage in interstitial lung disease.

Authors:  Keith C Meyer
Journal:  Clin Chest Med       Date:  2004-12       Impact factor: 2.878

8.  Recognition of E-cadherin on epithelial cells by the mucosal T cell integrin alpha M290 beta 7 (alpha E beta 7).

Authors:  P I Karecla; S J Bowden; S J Green; P J Kilshaw
Journal:  Eur J Immunol       Date:  1995-03       Impact factor: 5.532

9.  CD4 T Lymphocyte-mediated lung disease: steady state between pathological and tolerogenic immune reactions.

Authors:  Dunja Bruder; Astrid M Westendorf; Robert Geffers; Achim D Gruber; Marcus Gereke; Richard I Enelow; Jan Buer
Journal:  Am J Respir Crit Care Med       Date:  2004-08-11       Impact factor: 21.405

10.  Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma.

Authors:  Dominik Hartl; Barbara Koller; Alexander T Mehlhorn; Dietrich Reinhardt; Thomas Nicolai; Dolores J Schendel; Matthias Griese; Susanne Krauss-Etschmann
Journal:  J Allergy Clin Immunol       Date:  2007-04-06       Impact factor: 10.793

View more
  32 in total

1.  Five-year update on the mouse model of orthotopic lung transplantation: Scientific uses, tricks of the trade, and tips for success.

Authors:  Xue Lin; Wenjun Li; Jiaming Lai; Mikio Okazaki; Seiichiro Sugimoto; Sumiharu Yamamoto; Xingan Wang; Andrew E Gelman; Daniel Kreisel; Alexander Sasha Krupnick
Journal:  J Thorac Dis       Date:  2012-06-01       Impact factor: 2.895

2.  Analysis of the effects of cigarette smoke on staphylococcal virulence phenotypes.

Authors:  Elisa K McEachern; John H Hwang; Katherine M Sladewski; Shari Nicatia; Carola Dewitz; Denzil P Mathew; Victor Nizet; Laura E Crotty Alexander
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

3.  Macrophages from the upper and lower human respiratory tract are metabolically distinct.

Authors:  Katelyn S Lavrich; Adam M Speen; Andrew J Ghio; Philip A Bromberg; James M Samet; Neil E Alexis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-08-09       Impact factor: 5.464

Review 4.  Control of lung defence by mucins and macrophages: ancient defence mechanisms with modern functions.

Authors:  William J Janssen; Adrianne L Stefanski; Bruce S Bochner; Christopher M Evans
Journal:  Eur Respir J       Date:  2016-09-01       Impact factor: 16.671

5.  Acute 4,4'-Methylene Diphenyl Diisocyanate Exposure-Mediated Downregulation of miR-206-3p and miR-381-3p Activates Inducible Nitric Oxide Synthase Transcription by Targeting Calcineurin/NFAT Signaling in Macrophages.

Authors:  Chen-Chung Lin; Brandon F Law; Justin M Hettick
Journal:  Toxicol Sci       Date:  2020-01-01       Impact factor: 4.849

6.  Correlation between the Diagnostic Yield from the Bronchoalveolar Lavage Fluid Analysis and Clinicoradiological Findings in Sarcoidosis.

Authors:  Fatma Tokgöz Akyıl; Meltem Ağca; Hatice Öztürk; Esin Sonkaya; İpek Erdem; Esra Usta Bülbül; Fatma Özbaki; Reyhan Yıldız; Sümeyye Alparslan Bekir; Tülin Sevim
Journal:  Turk Thorac J       Date:  2020-01-01

Review 7.  Asthma Over the Age of 65: All's Well That Ends Well.

Authors:  Alan P Baptist; Paula J Busse
Journal:  J Allergy Clin Immunol Pract       Date:  2018 May - Jun

8.  Dual targeted immunotherapy via in vivo delivery of biohybrid RNAi-peptide nanoparticles to tumour-associated macrophages and cancer cells.

Authors:  João Conde; Chenchen Bao; Yeqi Tan; Daxiang Cui; Elazer R Edelman; Helena S Azevedo; Hugh J Byrne; Natalie Artzi; Furong Tian
Journal:  Adv Funct Mater       Date:  2015-06-01       Impact factor: 18.808

9.  Human Alveolar Macrophages May Not Be Susceptible to Direct Infection by a Human Influenza Virus.

Authors:  David B Ettensohn; Mark W Frampton; Joan E Nichols; Norbert J Roberts
Journal:  J Infect Dis       Date:  2016-09-06       Impact factor: 5.226

10.  In vivo characterization of alveolar and interstitial lung macrophages in rhesus macaques: implications for understanding lung disease in humans.

Authors:  Yanhui Cai; Chie Sugimoto; Mariluz Arainga; Xavier Alvarez; Elizabeth S Didier; Marcelo J Kuroda
Journal:  J Immunol       Date:  2014-02-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.